SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-275417
Filing Date
2023-11-13
Accepted
2023-11-13 08:24:27
Documents
3
Group Members
ACCESS INDUSTRIES HOLDINGS LLCACCESS INDUSTRIES MANAGEMENT, LLCLEN BLAVATNIK

Document Format Files

Seq Description Document Type Size
1 SC 13D d570190dsc13d.htm SC 13D 105428
2 EX-99.4 d570190dex994.htm EX-99.4 9605
3 EX-99.5 d570190dex995.htm EX-99.5 7932
  Complete submission text file 0001193125-23-275417.txt   124944
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Subject) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90268 | Film No.: 231395363
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACCESS INDUSTRIES, INC. 40 WEST 57TH STREET, 28TH FLOOR NEW YORK NY 10019
Business Address C/O ACCESS INDUSTRIES, INC. 40 WEST 57TH STREET, 28TH FLOOR NEW YORK NY 10019 212-247-6400
AI Biotechnology LLC (Filed by) CIK: 0001942670 (see all company filings)

IRS No.: 842172770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D